Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-γ-independent mechanism

European Journal of Immunology

Volumn 31, Issue 8, 2001, Pages 2313-2318

  Fujigaki, Suwako ^a,d,e   Saito, Kuniaki ^a,e   Sekikawa, Kenji ^a,d,e   Tone, Shigenobu ^a,c,d,e   Takikawa, Osamu ^c,d,e   Fujii, Hidehiko ^a,d,e   Wada, Hisayasu ^a,d,e   Noma, Akio ^a,e   Seishima, Mitsuru ^a,b,c,d,e  

^a GIFU UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF WOLLONGONG   (Australia)

^e GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IFN ; Indoleamine 2,3 dioxygenase; Lipopolysaccharide

Indexed keywords

ARYLFORMAMIDASE; ESSENTIAL AMINO ACID; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; LIPOPOLYSACCHARIDE; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SYNTHESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; GENE DISRUPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LIVER; LUNG PARENCHYMA; MALE; MONOCYTIC LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; CYTOKINES; ENZYME INDUCTION; GENE DELETION; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, MESSENGER; TRYPTOPHAN OXYGENASE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034850590     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S     Document Type: Article

References (30)

1. A mechanism for increased quinolinic acid formation following acute systemic immune stimulation
2. Tryptophan degradation inmice initiated by indoleamine 2,3-dioxygenase
3. Induction of indoleamine 2,3-dioxygenase: A mechanism of the antitumor activity of interferon-γ
4. Mechanism of interferon-γ action: Characterization of indoleamine 2,3-dioxygenase in cultured human cells inducedmby interferon-γ and evalution of the enzyme-mediated tryptophan degradation in its anticellular activity
5. Oxidative tryptophan metabolism in renal allograft recipients: Increased kynurenine synthesis is associated with inflammation and OKT3 therapy
6. Mecanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia
7. Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques
8. IFN-γ-mediated antimicrobial response
9. Sources of the neurotoxun quinolinic acid in the brain of HIV-1-infected patiants and retrovirus-infected macaques
10. Prevention of allogeneic fetal rejection by tryptophan catabolism
11. Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain
12. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
13. Early increases in TNF-α, IL-6 and IL-1β levels following transient cerebral ischemia in gerbil brain
14. Tumor necrosis factor release from lipopolysaccharide-stimulated human monocytes: Lipopolysaccharide tolerance in vitro
15. Characteristics of bacterial lipopolysaccharide induction of interleukin 1 synthesis and secretion by human monocytes
16. Differential regulation of IL 6, IL 1 A, IL 1 beta and TNF alpha production in LPS-stimulated human monocytes: Role of cyclic AMP
17. Differential priming for endotoxin-induced circulating cytokine production by tumor necrosis factor-alpha and interleukin 1 beta
18. Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes
19. Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1
20. Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures
21. Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12
22. Interleukin-4 inhibits indoleamin 2,3-dioxygenase expression in human monocytes
23. Modulation of cellular tryptophan metabolism in human fibroflasts by transforming growth factor-β: Selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression
24. Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages
25. Inhibition of propylene glycol stimulated gluconeogenesis by quinolinic acid in the fasting rat
26. Quinolinic acid: A modulator of the heart calcium channel in the rat and a binder of calcium ions
27. Quinolinic acid is a potent lipid peroxidant in rat brain homogenates
28. Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor alpha-deficient mice
29. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells)
30. Species differences in L-tryptophan-kynurenine pathway metabolism: Quantification of anthranilic acid and its related enzymes